^
+ Follow ASTRINGENT Tag
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1407674
                    [Title] => Alam n’yo ba?
                    [Summary] => 

Alam n’yo ba noong unang panahon, ginagamit ng mga Romans ang aluminum bilang astringent at pagtitina?

[DatePublished] => 2014-12-30 00:00:00 [ColumnID] => 0 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Para Malibang [SectionUrl] => para-malibang [URL] => ) [1] => Array ( [ArticleID] => 90568 [Title] => ‘Adulterated’ beauty product still being sold [Summary] => A beauty product, earlier found by the Bureau of Food and Drugs (BFAD) to have deviated from its indicated formulation, has been allowed to be sold to the public despite the possible public health risk involved.

A BFAD report said the RDL Babyface Astringent, was "not only adulterated but also misbranded" and that its factory in Davao City did not comply with the bureau’s "good manufacturing practice (GMP) policy" to make sure products are clean and of high quality to protect public health.
[DatePublished] => 2001-05-04 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Headlines [SectionUrl] => headlines [URL] => ) [2] => Array ( [ArticleID] => 86328 [Title] => BFAD warns company [Summary] => Bureau of Food and Drugs (BFAD) director William Torres warned the manufacturer of an astringent with cancellation of its license if it commits a third violation of BFAD regulations.

In a recent radio interview, Torres said RDL Pharmaceutical Laboratory in Davao City erred when it marketed the Special RDL Babyface Astringent, a whitening product, without the necessary certificate of registration.
[DatePublished] => 2001-04-29 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => 1194024 [AuthorName] => by Ella Oducayen [SectionName] => Nation [SectionUrl] => nation [URL] => ) [3] => Array ( [ArticleID] => 104091 [Title] => BFAD warns company [Summary] => Bureau of Food and Drugs (BFAD) director William Torres warned the manufacturer of an astringent with cancellation of its license if it commits a third violation of BFAD regulations.

In a recent radio interview, Torres said RDL Pharmaceutical Laboratory in Davao City erred when it marketed the Special RDL Babyface Astringent, a whitening product, without the necessary certificate of registration.
[DatePublished] => 2001-04-25 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => 1194024 [AuthorName] => by Ella Oducayen [SectionName] => Nation [SectionUrl] => nation [URL] => ) ) )
ASTRINGENT
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1407674
                    [Title] => Alam n’yo ba?
                    [Summary] => 

Alam n’yo ba noong unang panahon, ginagamit ng mga Romans ang aluminum bilang astringent at pagtitina?

[DatePublished] => 2014-12-30 00:00:00 [ColumnID] => 0 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Para Malibang [SectionUrl] => para-malibang [URL] => ) [1] => Array ( [ArticleID] => 90568 [Title] => ‘Adulterated’ beauty product still being sold [Summary] => A beauty product, earlier found by the Bureau of Food and Drugs (BFAD) to have deviated from its indicated formulation, has been allowed to be sold to the public despite the possible public health risk involved.

A BFAD report said the RDL Babyface Astringent, was "not only adulterated but also misbranded" and that its factory in Davao City did not comply with the bureau’s "good manufacturing practice (GMP) policy" to make sure products are clean and of high quality to protect public health.
[DatePublished] => 2001-05-04 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Headlines [SectionUrl] => headlines [URL] => ) [2] => Array ( [ArticleID] => 86328 [Title] => BFAD warns company [Summary] => Bureau of Food and Drugs (BFAD) director William Torres warned the manufacturer of an astringent with cancellation of its license if it commits a third violation of BFAD regulations.

In a recent radio interview, Torres said RDL Pharmaceutical Laboratory in Davao City erred when it marketed the Special RDL Babyface Astringent, a whitening product, without the necessary certificate of registration.
[DatePublished] => 2001-04-29 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => 1194024 [AuthorName] => by Ella Oducayen [SectionName] => Nation [SectionUrl] => nation [URL] => ) [3] => Array ( [ArticleID] => 104091 [Title] => BFAD warns company [Summary] => Bureau of Food and Drugs (BFAD) director William Torres warned the manufacturer of an astringent with cancellation of its license if it commits a third violation of BFAD regulations.

In a recent radio interview, Torres said RDL Pharmaceutical Laboratory in Davao City erred when it marketed the Special RDL Babyface Astringent, a whitening product, without the necessary certificate of registration.
[DatePublished] => 2001-04-25 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => 1194024 [AuthorName] => by Ella Oducayen [SectionName] => Nation [SectionUrl] => nation [URL] => ) ) )
abtest
Are you sure you want to log out?
X
Login

Philstar.com is one of the most vibrant, opinionated, discerning communities of readers on cyberspace. With your meaningful insights, help shape the stories that can shape the country. Sign up now!

Get Updated:

Signup for the News Round now

FORGOT PASSWORD?
SIGN IN
or sign in with